Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

ClinicalTrials.gov ID: NCT07449923

Public ClinicalTrials.gov record NCT07449923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Study identification

NCT ID
NCT07449923
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
EyePoint Pharmaceuticals, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 9, 2026 (Actual)
Primary completion
Oct 2027 (Estimated)
Completion
Oct 2028 (Estimated)
Last update posted
Oct 2, 2026

2026 – 2028

United States locations

U.S. sites
51
U.S. states
24
U.S. cities
47
Facility City State ZIP Site status
Associated Retina Consultans Gilbert Arizona 85297 —
Associated Retina Consultants - Phoenix Phoenix Arizona 85020 —
Phoenix Retina Clinical Trials, LLC - North Phoenix Phoenix Arizona 85050 —
Retina Macula Institute of Arizona Scottsdale Arizona 85255 —
Retina Vitreous Associates Medical Group Beverly Hills California 90211 —
Retina Consultants of Orange County Fullerton California 92835 —
South Coast Retina Center Long Beach California 90807 —
Retinal Consultants Medical Group - Modesto Modesto California 95356 —
Kaiser Permanente Oakland California 94611 —
Retina Consultants of Southern California Redlands California 92374 —
Bay Area Retina Associates Walnut Creek California 94598 —
Retina Specialists of Colorado - Arvada Arvada Colorado 80002 —
Connecticut Eye Consultants, P.C. Danbury Connecticut 06810 —
Coastal Eye Surgeons, LLC Greenwich Connecticut 06830 —
Retina Group of New England, PC Waterford Connecticut 06385 —
Retina Group of Florida - Fort Lauderdale Fort Lauderdale Florida 33308 —
Retina Specialty Institute Pensacola Florida 32503 —
Fort Lauderdale Eye Institute Plantation Florida 33324 —
MedEye Associates South Miami Florida 33143 —
Retina Vitreous Associates of Florida - Saint Petersburg St. Petersburg Florida 33711 —
Retina Vitreous Associates of Florida Tampa Florida 33617 —
Retina Associates Elmhurst Illinois 60126 —
University Retina and Macula Associates Lemont Illinois 60439 —
Illinois Retina Associates, S.C. Oak Park Illinois 60304 —
Associated Vitreoretinal & Uveitis Consultants - Carmel Carmel Indiana 46032 —
The Eye Care Institute Louisville Kentucky 40206 —
Retina Associates New Orleans Metairie Louisiana 70006 —
Cumberland Valley Retina Consultants Hagerstown Maryland 21740 —
Mid Atlantic Retina Specialists - Hagerstown Hagerstown Maryland 21740 —
Vitreo Retinal Associates, PC Worcester Massachusetts 01605 —
The Retina Institute St Louis Missouri 63128 —
Retina Center of New Jersey Bloomfield New Jersey 07003 —
Vision Research Center at Eye Associates of New Mexico Albuquerque New Mexico 87109 —
Retina Vitreous Surgeons of CNY, PC Liverpool New York 13088 —
Graystone Eye - Hickory Office Hickory North Carolina 28602 —
North Carolina Retina Associates Wake Forest North Carolina 27587 —
Retina Vitreous Center, PLLC Edmond Oklahoma 73013 —
Verum Research, LLC Eugene Oregon 97401 —
Wills Eye Hospital Philadelphia Pennsylvania 19107 —
Carolinas Centers for Sight, P.C. - Florence Campus Florence South Carolina 29501 —
Charles Retina Institute Germantown Tennessee 38138 —
Austin Clinical Research LLC Austin Texas 78750 —
Retina and Vitreous of Texas Bellaire Texas 77401 —
Retina Consultants of Texas Bellaire Texas 77401 —
San Antonio Eye Center San Antonio Texas 78215 —
Retina Associates of South Texas San Antonio Texas 78240 —
Retina Consultants of Texas The Woodlands Texas 77384 —
Tyler Retina Consultants Tyler Texas 75703 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —
The Retina Group of Washington Fairfax Virginia 22031 —
Eye Clinic of Wisconsin Wausau Wisconsin 54403 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07449923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07449923 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →